703803006: Mirabegron (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Adrenergic receptor agonist\Beta adrenergic receptor agonist\Selective beta-3 agonist\Mirabegron

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Sympathomimetic agent (substance)\Adrenergic receptor agonist\Beta adrenergic receptor agonist\Selective beta-3 agonist\Mirabegron

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3009012018 Mirabegron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3009836015 Mirabegron (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

54061000195118 mirabegron it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

825871000172112 mirabégron fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

69201000195118 Mirabegron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Mirabegron	Is a	Beta adrenergic receptor agonist	false	Inferred relationship	Some
Mirabegron	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Beta adrenergic receptor agonist (disposition)	false	Inferred relationship	Some
Mirabegron	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Beta-3 adrenergic receptor agonist	true	Inferred relationship	Some
Mirabegron	Is a	Selective beta-3 agonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing mirabegron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirabegron	Inferred relationship	Some	1
Mirabegron 25mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirabegron	Inferred relationship	Some
Mirabegron 50mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirabegron	Inferred relationship	Some
Mirabegron-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirabegron	Inferred relationship	Some	1
Mirabegron 50 mg prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirabegron	Inferred relationship	Some	1
Mirabegron 50 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirabegron	Inferred relationship	Some	1
Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirabegron	Inferred relationship	Some	1
Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirabegron	Inferred relationship	Some	1
Mirabegron only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirabegron	Inferred relationship	Some	1
Product containing only mirabegron in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirabegron	Inferred relationship	Some	1

This concept is not in any reference sets